Vitamin D has effects on many tissues, and hypovitaminosis D is frequent. In a French survey conducted among 1587 adults, vitamin D insufficiency (\<30ng/ml) has been reported in 80% of subjects, including 43% with moderate deficiency (\<20ng/ml) and 5% with severe deficiency (\<10ng/ml). Because of the possible consequences of hypovitaminosis D (osteomalacia in adults…), the number of vitamin D determination has increased ten-fold since 2005 in France, reaching 4.5 million € in 2011, and with it the costs for health insurance. However, there is currently no consensus on the strategy for detection, diagnosis and treatment of hypovitaminosis D. We propose to develop a predictive clinical score of hypovitaminosis D based on the accurate assessment of solar exposure, vitamin D intakes and hypovitaminosis D risk factors collected through a self-administered questionnaire.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
2,592
Patients will have a blood sampling at inclusion to measure vitamin D blood concentration.
Patients will fill a self-administered questionnaire the day of inclusion
Hospices Civils de Lyon - Pôle IMER
Lyon, France
25 (OH) vitamin D blood concentration
Vitamin D determination will be carried out for each center in a single laboratory by chemiluminescence technique. Vitamin D determination is the gold standard for the development and validation phases of the score. It will define the variables of the self-administered questionnaire to be included in the final score (development phase) and be the gold standard in the evaluation of the performance score (validation phase). The blood sample will be collected after the completion of the questionnaire, on the same day.
Time frame: The day of inclusion
Vitamin D concentration level
The ability of the score to classify adults in one of these three categories: * Category 1 : Vitamin D sufficiency (≥30 ng/ml) * Category 2 : Hypovitaminosis D between 30 and 10 ng/ml * Vitamin D insufficiency (\<30 ng/ml) * Vitamin D deficiency (\<20 ng/ml) * Category 3 : Severe deficiency (\<10 ng/ml)
Time frame: The day of inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.